Table 3

Patient preferences and true stool responder data

Ondansetron
No
Placebo
Yes
Ondansetron
Yes
Placebo
No
Ondansetron
No
Placebo
No
Ondansetron
Yes
Placebo
Yes
Risk ratio to prefer ‘ondansetron but not placebo’ compared with ‘placebo but not ondansetron’
ITT (N=94)
 Preference, N (%)15 (16)70 (74)9 (10)0 (0)4.7 (2.7 to 8.2)
 p value<0.001
Continue, N (%)15 (16)67 (71)11 (12)1 (1)4.5 (2.6 to 7.8)
 p value<0.001
 Adequate Relief, N (%)13 (14)61 (65)17 (18)3 (3)4.7 (2.6 to 8.5)
 p value<0.001
PPA (N=86)
 Preference, N (%)13 (15)66 (77)7 (8)0 (0)5.1 (2.8 to 9.2)
 p value<0.001
 Continue, N (%)14 (16)64 (74)7 (8)1 (1)4.6 (2.6 to 8.2)
 p value<0.001
 Adequate Relief, N(%)11 (13)58 (67)14 (16)3 (3)5.3 (2.8 to 10.0)
 p value<0.001
Response data
ITT (N=98)
True stool responder
 Response, N (%)6 (6)44 (45)14 (14)34 (35)7.3 (3.1 to 17.2)
 p value<0.001
PPA (N=90)
 Response, N (%)5 (6)43 (48)11 (12)31 (34)8.6 (3.4 to 21.7)
 p value<0.001
  • *Ratios are shown for probability that people would prefer a particular choice compared with the choice ‘Placebo yes but ondansetron no’. For example, it is much more probable (4.2 times, 95% CI 2.5 to 7.1) that patients prefer ‘Ondansetron but not placebo’ compared with ‘Placebo but not ondansetron’. The same applies to ‘continue’ and ‘adequate relief’ options. Data show that it is more probable (7.3 times, 95% CI 3.1 to 17.2) to respond to ondansetron but not placebo compared with placebo but not ondansetron.